Try from €1.50 / week
A COMPREHENSIVE SERIES OF ARTICLES ON THIS TOPIC
PowderJect is to start clinical trials of a vaccine to combat hepatitis B as part of its continuing strategic alliance with GlaxoSmithKline.
Fri, 23 Feb, 2001
News
Monday, December 29, 2025 - 2:00 PM
Monday, December 29, 2025 - 12:00 PM
Monday, December 29, 2025 - 3:00 PM